"Adderall 30mg" is a strength that people researching ADHD medication often come across when comparing US and UK information online. This page explains what that strength means, how it differs between Adderall's two main formulations, whether it has any lawful route into the UK, and what safety points matter if amphetamine-type stimulant treatment is being considered. It's general information for a UK audience — not personalised medical advice, and not a substitute for assessment by a qualified prescriber.
What Adderall 30mg contains
Adderall combines four amphetamine salts in a fixed ratio, delivering a mix of dextroamphetamine and levoamphetamine. It's sold in the US in a range of strengths, and 30mg sits toward the higher end of that range. Critically, "30mg" on its own doesn't describe a single medicine — it describes a quantity of active ingredient that exists in two pharmacologically different Adderall products, covered below. Nothing on this page is intended to help anyone select, start or adjust a dose; strength and formulation decisions are for a prescriber to make after individual assessment.
People researching this specific strength from the UK are usually doing one of two things: comparing a dose they (or someone they know) were prescribed while living or studying abroad against what's available here, or trying to understand US-focused information they've come across online. Either way, the practical questions — availability, safety and what a UK specialist would actually offer — are answered below.
Immediate-release Adderall 30mg vs Adderall XR 30mg: not interchangeable
These are two distinct formulations that happen to share a milligram figure:
- Adderall (immediate-release) 30mg releases its full dose promptly, so effects begin relatively quickly and wear off within a few hours. Immediate-release Adderall is generally taken more than once a day to maintain coverage.
- Adderall XR 30mg is an extended-release capsule, engineered to release part of the dose immediately and the remainder later in the day, intended to work from a single morning dose.
Because the release profile, duration of effect and dosing schedule differ, a 30mg dose of one formulation does not translate directly to a 30mg dose of the other. Switching between immediate-release and XR versions, or assuming equivalence based on the number alone, is a clinical decision that requires a prescriber's involvement — not something to work out independently.
This distinction matters beyond terminology. Immediate-release and extended-release stimulants behave differently across a day — coverage, how effects taper toward the evening, and how a missed or delayed dose affects the rest of the day can all differ between formulations. It's one of several reasons UK prescribers treat formulation as a deliberate clinical choice for each patient, not an interchangeable detail.
Is Adderall 30mg available in the UK?
Adderall does not hold a UK marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA), and it does not appear among the medicines listed in NICE guideline NG87, which sets out how UK clinicians approach ADHD diagnosis and treatment. As a result, Adderall is not a routine first-line ADHD medicine on the NHS or in UK private practice, and no UK pharmacy stocks it as standard. This applies equally to private clinics: UK licensing status doesn't change based on who is prescribing, so a private specialist faces the same constraint as an NHS one.
That doesn't mean the drug is completely banned in the UK. Unlicensed medicines — including some imported products — can be supplied in narrow, specialist-supervised circumstances, such as a specialist continuing a treatment that was already established abroad. The NHS Business Services Authority's dictionary of medicines and devices (dm+d) includes a record for an imported Adderall XR 30mg pack, which reflects that such supply exists at a limited, clinically-governed level rather than as a generally available or online-orderable option. Anyone bringing controlled medicines into the UK, or asking a specialist about continuing an existing prescription, should also be aware of GOV.UK's guidance on personal licences for controlled drugs, since amphetamine-based medicines are Schedule 2 Controlled Drugs.
Safety considerations
The points below are general safety themes associated with amphetamine-type stimulants, not an exhaustive list and not a substitute for a prescriber's individual advice:
- Cardiovascular monitoring. Prescribers typically check personal and family cardiovascular history and take a baseline blood pressure and heart rate reading before starting treatment, with periodic monitoring afterwards.
- Sleep. Stimulant medicines can make falling asleep harder, especially if a dose is taken later in the day.
- Appetite. Reduced appetite is common, which is one reason weight (and growth, in children) is often monitored during treatment.
- Mental-health effects. Stimulants can affect mood or anxiety levels, and in rare cases can contribute to new psychiatric symptoms; any prescriber will usually ask about mental-health history beforehand.
- Interactions. Amphetamine-type medicines can interact with other drugs, including MAOIs and other substances that affect heart rhythm or serotonin levels — a full medicines list should always be shared with a prescriber.
- Misuse and dependence potential. As Schedule 2 Controlled Drugs, amphetamine-type stimulants carry a recognised potential for misuse and dependence, which is part of why supply and monitoring are tightly controlled and why they should never be shared with anyone else.
- Driving. Amphetamine-type medicines can have implications for driving in the UK; see GOV.UK's guidance on ADHD and driving for the current position.
Seek urgent help if you experience severe symptoms
This page cannot assess anyone's individual symptoms. Call 999 or go to A&E immediately for severe chest pain or pressure, fainting, an irregular or racing heartbeat that doesn't settle, signs of a serious allergic reaction (such as swelling of the face or throat, or difficulty breathing), or severe agitation, confusion or hallucinations. For less urgent concerns about a medicine you've already been prescribed, contact your GP, prescriber, or NHS 111.
UK ADHD treatment options
UK ADHD treatment follows NICE guideline NG87, which sets out the UK-licensed medicines a specialist can consider — this section is a general overview, not a recommendation for any individual:
- Methylphenidate — the most commonly prescribed UK ADHD stimulant, available in several brand and release formulations. See NHS information on methylphenidate for adults.
- Lisdexamfetamine (Elvanse) — a once-daily prodrug that converts to dexamfetamine in the body, often described as the closest UK-licensed relative to Adderall.
- Dexamfetamine — a shorter-acting amphetamine-type stimulant, sometimes prescribed on its own.
- Atomoxetine (Strattera) — a non-stimulant option, generally considered when stimulant medicines aren't suitable or haven't worked well.
Which of these (if any) is appropriate, and at what dose, is decided individually by a specialist after formal assessment — not by matching a specific Adderall strength to a UK-licensed equivalent.
Information only, not medical advice
This page provides general information for a UK audience. It does not diagnose, prescribe or replace an assessment by a qualified clinician. Always speak to a GP or specialist about your own symptoms, diagnosis or treatment.
Controlled Drug status
Amphetamine-type medicines, including Adderall, lisdexamfetamine and dexamfetamine, are Schedule 2 Controlled Drugs under UK law. They must only be obtained and used under a valid UK prescription and appropriate clinical supervision.
Next steps
If you're trying to understand where Adderall fits against what's actually prescribed in the UK, our Adderall UK guide and Adderall alternatives guide go into more detail, and our ADHD treatment overview explains the full UK diagnosis-to-prescription pathway.
Sources: NICE NG87 recommendations · NHS: methylphenidate (adults) · NHSBSA dm+d: Adderall XR 30mg (imported) · GOV.UK: controlled drugs personal licences · GOV.UK: ADHD and driving.
Last reviewed: 29 August 2026.